| Financial Year |
March 31 2023 |
| Monetary Funds |
2,256,729,978.40 |
| Held-for-trading Financial Assets |
224,803,380.53 |
| Notes Receivable |
62,077,948.87 |
| Accounts Receivable |
540,296,462.63 |
| Advances to Suppliers |
110,731,441.07 |
| Other Receivables |
130,027,049.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,221,421,786.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,854,395.19 |
| Total Current Assets |
4,735,956,789.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
165,549,362.11 |
| Investment Properties |
-- |
| Fixed Assetes |
2,073,123,744.76 |
| Under-construction Projects |
838,650,475.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,550,283,964.59 |
| R&D expenses |
-- |
| Goodwill |
434,354,984.37 |
| Long-Term Deferred and Prepaid Expenses |
278,839,399.97 |
| Deferred Income Tax Assets |
65,076,362.41 |
| Other Non-Current Assets |
228,797,350.11 |
| Sub-Total of Non-Current Assets |
8,217,882,747.53 |
| Total Assets |
12,953,839,537.38 |
| Short-Term Loans |
1,506,508,908.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,974,553.98 |
| Accounts Payable |
483,935,083.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,990,699.62 |
| Taxes Payable |
218,038,684.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,216,105.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
125,319,816.81 |
| Other Current Liabilities |
48,633,447.68 |
| Sub-Total of Current Liabilities |
2,708,723,050.91 |
| Long-term Loans |
374,527,100.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
328,641.87 |
| Deferred Income Tax Liabilities |
1,262,122,938.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,643,520,850.66 |
| Total Liabilities |
4,352,243,901.57 |
| Paid-In Capital(Or Share Stock) |
1,244,062,083.00 |
| Capital Surplus |
4,611,277,070.20 |
| Surplus Reserve |
233,834,440.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,501,267,187.27 |
| Minority Stockholder's Interest |
11,185,204.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,590,410,431.64 |
| Owner's Equity（Stockholder's Equity） |
8,601,595,635.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,953,839,537.38 |
